| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 01/21/1997 | US5595902 DNA encoding human protein kinase C (iota) |
| 01/21/1997 | CA2028235C Condensed purine derivatives |
| 01/16/1997 | WO1997001638A1 Omp26 antigen from haemophilus influenzae |
| 01/16/1997 | WO1997001569A1 Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a |
| 01/16/1997 | WO1997001354A1 Il-8 antagonists for treatment of inflammatory disorders and asthma |
| 01/16/1997 | WO1997001353A1 Use of il-11 to treat inflammation |
| 01/16/1997 | WO1997001335A1 Di- and trivalent small molecule selectin inhibitors |
| 01/16/1997 | CA2225405A1 Omp26 antigen from haemophilus influenzae |
| 01/16/1997 | CA2224346A1 Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a |
| 01/16/1997 | CA2222024A1 Il-8 antagonists for treatment of inflammatory disorders and asthma |
| 01/16/1997 | CA2220554A1 Use of il-11 to treat inflammation |
| 01/15/1997 | EP0753004A1 Antagonists of endothelin receptors |
| 01/15/1997 | EP0752990A1 Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis |
| 01/15/1997 | EP0752986A1 N-heterocyclyl sulphonamide derivatives and their use as endothelin antagonists |
| 01/15/1997 | EP0752985A1 Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors |
| 01/15/1997 | EP0752871A1 Adhesion inhibiting composition |
| 01/15/1997 | EP0752854A1 Pyrimidine or triazine carboxylic acid derivatives to be used as medicaments |
| 01/15/1997 | CN1140455A Diastereomeric pure trifluoromethyl ketone peptide derivs. as inhibitors of human leukocyte elastase |
| 01/15/1997 | CN1140174A Piperidine derivatives, process for preparation thereof and application thereof in therapeutics |
| 01/15/1997 | CN1140173A Novel pyrido |3,2-e¨ pyrazinones with anti-asthmatic action and processes for their manufacture |
| 01/14/1997 | US5594107 Chimeric protein comprising an RTX-family cytotoxin and interferon-2 or interferon |
| 01/14/1997 | US5594022 Carbamates |
| 01/14/1997 | US5594008 Pyrrolidine derivatives inhibitors of leukotriene biosynthesis |
| 01/14/1997 | US5593992 Cytokine inhibitors |
| 01/14/1997 | US5593991 Imidazole compounds, use and process of making |
| 01/14/1997 | US5593671 Method of attenuating lung capillary leak in a mammal |
| 01/08/1997 | EP0751932A1 Vitamin-d amide derivatives |
| 01/08/1997 | EP0668863B1 Quinuclidine derivative as substance p antagonist |
| 01/08/1997 | EP0469075B1 Use of lipoxin a 4? and its derivatives as antagonists for slow-reacting substances of anaphylaxis |
| 01/08/1997 | CN1139931A Cyclic neurokinin a antagonists |
| 01/08/1997 | CN1139928A Novel compound |
| 01/07/1997 | US5591776 Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV |
| 01/07/1997 | US5591769 Cyclic imino derivatives and pharmaceutical compositions containing them |
| 01/07/1997 | US5591761 Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 01/07/1997 | US5591718 Neutrophil activating factors |
| 01/07/1997 | CA2043715C Imidazonaphthyridine derivatives |
| 01/07/1997 | CA2033497C 3-aminopiperidine derivatives and related nitrogen containing heterocycles |
| 01/03/1997 | WO1997000079A1 P-selectin ligands and related molecules and methods |
| 01/03/1997 | CA2224625A1 P-selectin ligands and related molecules and methods |
| 01/02/1997 | EP0750909A1 The use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence |
| 01/02/1997 | EP0750666A1 HUMAN trk RECEPTORS AND NEUROTROPHIC FACTOR INHIBITORS |
| 01/02/1997 | EP0750511A1 Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor |
| 01/01/1997 | CN1139435A New ginkgolide derivatives and process for preparing them |
| 01/01/1997 | CN1139429A Process for the preparation of leukotriene antagonists |
| 01/01/1997 | CN1139384A Use of mometasone furoate for treating airway passage and lung diseases |
| 12/31/1996 | US5589514 Arylcycloalkyl derivatives, their production and their use |
| 12/31/1996 | US5589489 Cyclic amide derivatives for treating asthma |
| 12/31/1996 | US5589487 Piperidine derivatives and process for their production |
| 12/31/1996 | US5589471 Vitamin D analogues containing a hydroxy or alkylated hydroxy group in the 20-position |
| 12/31/1996 | US5589047 Using dielectrophoresis for genetic engineering |
| 12/27/1996 | WO1996041873A1 Dry powder formulations of polynucleotide complexes |
| 12/27/1996 | WO1996041807A1 Rapamycin derivatives |
| 12/27/1996 | WO1996041645A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations |
| 12/27/1996 | WO1996041626A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 12/27/1996 | WO1996041625A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor |
| 12/27/1996 | EP0749964A1 N-Heterocyclyl biphenyl sulfonamides |
| 12/27/1996 | EP0749429A1 3,5-disubstituted and 3,5,6-trisubstituted 2-isoxazolines and isoxazoles, process for preparing the same and their use as medicaments |
| 12/27/1996 | EP0749428A1 Isoxazoline compounds as inhibitors of tnf release |
| 12/27/1996 | EP0749417A1 Cyano compounds and preparations thereof |
| 12/27/1996 | EP0749313A1 Method for treating 5ht 2b receptor related conditions |
| 12/27/1996 | EP0749307A1 Isoxazoline compounds as 5-lipoxygenase inhibitors |
| 12/27/1996 | EP0749306A1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| 12/27/1996 | EP0500853B1 Phenylethanolamines, drugs containing these compounds, and a method of preparing them |
| 12/27/1996 | CA2224563A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations |
| 12/27/1996 | CA2224517A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 12/27/1996 | CA2224379A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor |
| 12/27/1996 | CA2224156A1 Dry powder formulations of polynucleotide complexes |
| 12/25/1996 | CN1138475A Medicine for treatment of cough |
| 12/24/1996 | US5587376 Antiischemic agents, decongestants |
| 12/19/1996 | WO1996040963A1 Cationic lipid:dna complexes for gene targeting |
| 12/19/1996 | WO1996040945A2 Nucleic acid respiratory syncytial virus vaccines |
| 12/19/1996 | WO1996040911A1 Modified steroid hormones for gene therapy and methods for their use |
| 12/19/1996 | WO1996040681A1 N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists |
| 12/19/1996 | WO1996040638A1 Heteroaryl diol acids as leukotriene antagonists |
| 12/19/1996 | WO1996040636A1 Catechol diethers derivatives useful as pharmaceutical agents |
| 12/19/1996 | WO1996040266A1 Method of treatment for asthma |
| 12/19/1996 | WO1996040224A1 Regulation of cytokine synthesis and release |
| 12/19/1996 | WO1996040199A1 Methods of inhibiting phagocytosis |
| 12/19/1996 | WO1996040184A1 New cryptophycins from synthesis |
| 12/19/1996 | WO1996040169A1 Bacterial inhibition with an oligosaccharide compound |
| 12/19/1996 | WO1996040162A1 Method of treatment for lung diseases using antisense oligonucleotides |
| 12/19/1996 | WO1996040143A1 Imidazole compounds |
| 12/19/1996 | WO1996040135A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS |
| 12/19/1996 | WO1996040125A1 Anti-viral compounds |
| 12/19/1996 | WO1996040124A1 Anti-viral compounds |
| 12/19/1996 | WO1996040123A1 Antigen-processing cell-targeted conjugates |
| 12/19/1996 | WO1996040117A1 Methods of treating microbial infections |
| 12/19/1996 | WO1996040114A1 Methods of inhibiting pneumocystis carinii pneumonia and compounds useful therefor |
| 12/19/1996 | WO1996040059A1 Dinucleotides useful for the treatment of lung disease |
| 12/19/1996 | CA2224102A1 Bacterial inhibition with an oligosaccharide compound |
| 12/19/1996 | CA2223928A1 Cationic lipid:dna complexes for gene targeting |
| 12/19/1996 | CA2223717A1 Modified steroid hormones for gene therapy and methods for their use |
| 12/19/1996 | CA2223610A1 Nucleic acid respiratory syncytial virus vaccines |
| 12/19/1996 | CA2223533A1 Imidazole compounds |
| 12/19/1996 | CA2223299A1 Anti-viral compounds |
| 12/19/1996 | CA2223093A1 Anti-viral compounds |
| 12/19/1996 | CA2221746A1 Alpha 1a adrenergic receptor antagonists |
| 12/19/1996 | CA2221601A1 Regulation of cytokine synthesis and release |
| 12/18/1996 | EP0748377A1 IMPROVED DNase LIQUID SOLUTIONS |
| 12/18/1996 | EP0748320A1 Prodrugs of morpholine tachykinin receptor antagonists |